首页 | 本学科首页   官方微博 | 高级检索  
   检索      

ALI/ARDS患者糖皮质激素的治疗效果和时机
引用本文:曹照龙,何权瀛.ALI/ARDS患者糖皮质激素的治疗效果和时机[J].医学与哲学,2007,28(2):14-15,28.
作者姓名:曹照龙  何权瀛
作者单位:北京大学人民医院呼吸内科 北京100044
摘    要:急性肺损伤/急性呼吸窘迫综合征(ALI/ARDS)是临床各科经常遇到的急症,其发病机制主要是中性粒细胞向炎症部位的移动,释放出大量的炎性介质和细胞因子,引起肺泡毛细血管膜通透性增高,弥漫性肺损伤和蛋白性肺泡水肿液聚集等病理生理改变。临床表现为呼吸困难、呼吸窘迫、顽固的低氧血症,虽然使用机械通气和呼气末正压通气(PEEP)后,其病死率有所下降,但仍然维持在50%左右。就糖皮质激素的作用机制,对不同原因引起的ALI/ARDS治疗效果,使用时机作一综述,期望对ALI/ARDS治疗过程中糖皮质激素的使用予以规范。

关 键 词:急性肺损伤/急性呼吸窘迫综合征  糖皮质激素  治疗效果  时机
文章编号:1002-0772(2007)01-0014-03
修稿时间:2007-01-20

Treatment Efficary and Apply Juncture of Glucocorticoid of Acute Lung Injury and Acute Respiratory Distress Syndrome
CAO Zhao-long , HE Quan-ying ,.Treatment Efficary and Apply Juncture of Glucocorticoid of Acute Lung Injury and Acute Respiratory Distress Syndrome[J].Medicine & Philosophy:Humanistic & Social Medicine Edition,2007,28(2):14-15,28.
Authors:CAO Zhao-long  HE Quan-ying  
Abstract:Acute lung injury and acute respiratory distress syndrome(ALI/ARDS) is a popular emergency of all clinician.the pathogenesis of ALI/ARDS is migration of neutrophil to inflammation site.which release massive inflammatory mediator and cytokines. It can increase alveolar-capillary membrane permeability, diffuse alveolar damage, alveolar pulmonary edema. Clinical manifestation is dyspnea, distress, intractable hypoxemia. The mortality sustains about 50%, although we use the mechanical ventilation and post end-expiratory pressure(PEEP), the mortality is decrease in some degree.To overview the mechanism of glucocorticoid, effect of ALI/ARDS of defferent causes,and apply juncture. We hope it may specifit treatment of glucocorticoid to ALI/ARDS.
Keywords:acute lung injury and acute respiratory distress syndrome  glucocorticoid  treatment efficacy  apply juncture
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号